XL999 Terminated Phase 2 Trials for Renal Cell Carcinoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00277316Study of XL999 in Patients With Metastatic Renal Cell Carcinoma